Daniel George Wildman - Nov 8, 2022 Form 3 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Nov 8, 2022
Transactions value $
$0
Form type
3
Date filed
11/9/2022, 04:57 PM
Next filing
Sep 8, 2023

No securities are beneficially owned.